Biomarkers for Alzheimer's disease—preparing for a new era of disease-modifying therapies

H Zetterberg, BB Bendlin - Molecular psychiatry, 2021 - nature.com
Clinical trial results presented in 2019 suggest that antibody-based removal of cerebral
amyloid β (Aβ) plaques may possibly clear tau tangles and modestly slow cognitive decline …
被引用次数：308 相关文章
[HTML] nih.gov

[HTML][HTML] Biomarkers for Alzheimer's disease–preparing for a new era of disease-modifying therapies

H Zetterberg, BB Bendlin - Molecular psychiatry, 2021 - ncbi.nlm.nih.gov
Clinical trial results presented in 2019 suggest that antibody-based removal of cerebral
amyloid β (Aβ) plaques may possibly clear tau tangles and modestly slow cognitive decline …

Biomarkers for Alzheimer's disease—preparing for a new era of disease-modifying therapies

H Zetterberg, BB Bendlin - Molecular Psychiatry, 2020 - discovery.ucl.ac.uk
Clinical trial results presented in 2019 suggest that antibody-based removal of cerebral
amyloid β (Aβ) plaques may possibly clear tau tangles and modestly slow cognitive decline …

Biomarkers for Alzheimer's disease—Preparing for a new era of disease-modifying therapies.

H Zetterberg, BB Bendlin - Molecular Psychiatry, 2021 - psycnet.apa.org
Clinical trial results presented in 2019 suggest that antibody-based removal of cerebral
amyloid β (Aβ) plaques may possibly clear tau tangles and modestly slow cognitive decline …

Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies.

H Zetterberg, BB Bendlin - Molecular Psychiatry, 2020 - europepmc.org
Clinical trial results presented in 2019 suggest that antibody-based removal of cerebral
amyloid β (Aβ) plaques may possibly clear tau tangles and modestly slow cognitive decline …

[引用][C] Biomarkers for Alzheimer's disease—preparing for a new era of disease-modifying therapies

H Zetterberg, BB Bendlin - Molecular Psychiatry, 2020 - cir.nii.ac.jp
Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Biomarkers for Alzheimer's disease--preparing for a new era of disease-modifying therapies.

H Zetterberg, BB Bendlin - Molecular Psychiatry, 2021 - go.gale.com
Clinical trial results presented in 2019 suggest that antibody-based removal of cerebral
amyloid [beta](A [beta]) plaques may possibly clear tau tangles and modestly slow cognitive …

Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies

H Zetterberg, BB Bendlin - Molecular psychiatry, 2021 - pubmed.ncbi.nlm.nih.gov
Clinical trial results presented in 2019 suggest that antibody-based removal of cerebral
amyloid β (Aβ) plaques may possibly clear tau tangles and modestly slow cognitive decline …